Ram Weiss1, Satish K Garg2, Richard M Bergenstal3, David C Klonoff4, Bruce W Bode5, Timothy S Bailey6, James Thrasher7, Frank Schwartz8, John B Welsh9, Francine R Kaufman10. 1. Department of Human Metabolism and Nutrition, Hebrew University, and the Department of Pediatrics, Hadassah Medical Center, Jerusalem, Israel. 2. University of Colorado Denver, Aurora, CO, USA. 3. International Diabetes Center, Minneapolis, MN, USA. 4. Mills-Peninsula Health Services, San Mateo, CA, USA. 5. Atlanta Diabetes Associates, Atlanta, GA, USA. 6. AMCR Institute, Escondido, CA, USA. 7. Arkansas Diabetes and Endocrinology Center, Little Rock, AR, USA. 8. Ohio University College of Osteopathic Medicine, Athens, OH, USA. 9. Medtronic, Inc., Northridge, CA, USA john.b.welsh@medtronic.com. 10. Medtronic, Inc., Northridge, CA, USA.
Abstract
BACKGROUND:Hypoglycemia varies between patients with type 1 diabetes and is the main obstacle to therapy intensification. We investigated known and potential risk factors for hypoglycemia in subjects with type 1 diabetes. METHOD: In the ASPIRE In-Home study (NCT01497938), a randomized trial of the threshold suspend (TS) feature of sensor-augmented insulin pump (SAP) therapy, subjects' propensity to nocturnal hypoglycemia (NH) was established in a 2-week run-in phase and assessed in a 3-month study phase via continuous glucose monitoring. Categorical variables were tested for association with NH rates in both phases. RESULTS:Elevated rates of NH were significantly associated with baseline A1C ≤7%, with bolus insulin deliveries unassisted by the bolus estimation calculator, and with assignment to the control group during the study phase. CONCLUSIONS: Routine use of the TS feature and the bolus estimation calculator are strategies that may reduce the risk of NH.
RCT Entities:
BACKGROUND:Hypoglycemia varies between patients with type 1 diabetes and is the main obstacle to therapy intensification. We investigated known and potential risk factors for hypoglycemia in subjects with type 1 diabetes. METHOD: In the ASPIRE In-Home study (NCT01497938), a randomized trial of the threshold suspend (TS) feature of sensor-augmented insulin pump (SAP) therapy, subjects' propensity to nocturnal hypoglycemia (NH) was established in a 2-week run-in phase and assessed in a 3-month study phase via continuous glucose monitoring. Categorical variables were tested for association with NH rates in both phases. RESULTS: Elevated rates of NH were significantly associated with baseline A1C ≤7%, with bolus insulin deliveries unassisted by the bolus estimation calculator, and with assignment to the control group during the study phase. CONCLUSIONS: Routine use of the TS feature and the bolus estimation calculator are strategies that may reduce the risk of NH.
Authors: Satish Garg; Ronald L Brazg; Timothy S Bailey; Bruce A Buckingham; Robert H Slover; David C Klonoff; John Shin; John B Welsh; Francine R Kaufman Journal: Diabetes Technol Ther Date: 2012-02-08 Impact factor: 6.118
Authors: Annalisa Blasetti; Concetta Di Giulio; Anna Maria Tocco; Alberto Verrotti; Stefano Tumini; Francesco Chiarelli; Emma Altobelli Journal: Pediatr Diabetes Date: 2010-08-18 Impact factor: 4.866
Authors: Richard M Bergenstal; William V Tamborlane; Andrew Ahmann; John B Buse; George Dailey; Stephen N Davis; Carol Joyce; Tim Peoples; Bruce A Perkins; John B Welsh; Steven M Willi; Michael A Wood Journal: N Engl J Med Date: 2010-06-29 Impact factor: 91.245
Authors: Thomas Danne; Olga Kordonouri; Martin Holder; Holger Haberland; Sven Golembowski; Kerstin Remus; Sara Bläsig; Tanja Wadien; Susanne Zierow; Reinhard Hartmann; Andreas Thomas Journal: Diabetes Technol Ther Date: 2011-08-09 Impact factor: 6.118
Authors: Ronald L Brazg; Timothy S Bailey; Satish Garg; Bruce A Buckingham; Robert H Slover; David C Klonoff; Xuan Nguyen; John Shin; John B Welsh; Scott W Lee Journal: J Diabetes Sci Technol Date: 2011-11-01
Authors: David C Klonoff; Richard M Bergenstal; Satish K Garg; Bruce W Bode; Melissa Meredith; Robert H Slover; Andrew Ahmann; John B Welsh; Scott W Lee Journal: J Diabetes Sci Technol Date: 2013-07-01
Authors: Richard M Bergenstal; David C Klonoff; Satish K Garg; Bruce W Bode; Melissa Meredith; Robert H Slover; Andrew J Ahmann; John B Welsh; Scott W Lee; Francine R Kaufman Journal: N Engl J Med Date: 2013-06-22 Impact factor: 91.245
Authors: Pratik Choudhary; John Shin; Yongyin Wang; Mark L Evans; Peter J Hammond; David Kerr; James A M Shaw; John C Pickup; Stephanie A Amiel Journal: Diabetes Care Date: 2011-09 Impact factor: 19.112